dimethylglycine has been researched along with Autism in 5 studies
dimethylglycine: metabolic product of calcium pangamate; mutagen when mixed with nitrite; RN given refers to parent cpd
N,N-dimethylglycine : An N-methylglycine that is glycine carrying two N-methyl substituents.
Excerpt | Relevance | Reference |
---|---|---|
"Oxytocin is expected as a novel therapeutic agent for autism spectrum disorder (ASD) core symptoms." | 9.41 | Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms. ( Benner, S; Eriguchi, Y; Kameno, Y; Kasai, K; Kato, Y; Kojima, M; Kosaka, H; Kuroda, M; Kuwabara, H; Munesue, T; Murayama, C; Nishimura, T; Okada, T; Ozaki, N; Tsuchiya, K; Yamasue, H; Yassin, W, 2021) |
"N,N-dimethylglycine, a dietary supplement, has been reported to be beneficial in children with autism and pervasive developmental disorder." | 9.09 | Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder. ( Cauller, PL; Dodd, M; Kendall, PR; Kern, JK; Mehta, PJ; Miller, VS, 2001) |
"Globally, the prevalence of autism is estimated to be less than 1%, especially in high- -income countries." | 6.82 | Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders. ( Bhardwaj, S; Chopra, C; Dhanjal, DS; Kuca, K; Nepovimova, E; Patocka, J; Plucar, B; Singh, R; Valis, M, 2022) |
" The major methodologic weaknesses of the study are thought to be the low dosage of DMG and the small sample size." | 6.69 | A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. ( Bolman, WM; Richmond, JA, 1999) |
"Oxytocin is expected as a novel therapeutic agent for autism spectrum disorder (ASD) core symptoms." | 5.41 | Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms. ( Benner, S; Eriguchi, Y; Kameno, Y; Kasai, K; Kato, Y; Kojima, M; Kosaka, H; Kuroda, M; Kuwabara, H; Munesue, T; Murayama, C; Nishimura, T; Okada, T; Ozaki, N; Tsuchiya, K; Yamasue, H; Yassin, W, 2021) |
"N,N-dimethylglycine, a dietary supplement, has been reported to be beneficial in children with autism and pervasive developmental disorder." | 5.09 | Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder. ( Cauller, PL; Dodd, M; Kendall, PR; Kern, JK; Mehta, PJ; Miller, VS, 2001) |
"Globally, the prevalence of autism is estimated to be less than 1%, especially in high- -income countries." | 2.82 | Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders. ( Bhardwaj, S; Chopra, C; Dhanjal, DS; Kuca, K; Nepovimova, E; Patocka, J; Plucar, B; Singh, R; Valis, M, 2022) |
" The major methodologic weaknesses of the study are thought to be the low dosage of DMG and the small sample size." | 2.69 | A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. ( Bolman, WM; Richmond, JA, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Dhanjal, DS | 1 |
Bhardwaj, S | 1 |
Chopra, C | 1 |
Singh, R | 1 |
Patocka, J | 1 |
Plucar, B | 1 |
Nepovimova, E | 1 |
Valis, M | 1 |
Kuca, K | 1 |
Kato, Y | 1 |
Kuwabara, H | 1 |
Okada, T | 1 |
Munesue, T | 1 |
Benner, S | 1 |
Kuroda, M | 1 |
Kojima, M | 1 |
Yassin, W | 1 |
Eriguchi, Y | 1 |
Kameno, Y | 1 |
Murayama, C | 1 |
Nishimura, T | 1 |
Tsuchiya, K | 1 |
Kasai, K | 1 |
Ozaki, N | 1 |
Kosaka, H | 1 |
Yamasue, H | 1 |
Xia, RR | 1 |
Bolman, WM | 1 |
Richmond, JA | 1 |
Kern, JK | 1 |
Miller, VS | 1 |
Cauller, PL | 1 |
Kendall, PR | 1 |
Mehta, PJ | 1 |
Dodd, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Galantamine Versus Placebo in Childhood Autism[NCT00252603] | Phase 3 | 20 participants | Interventional | 2004-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for dimethylglycine and Autism
Article | Year |
---|---|
Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders.
Topics: Autism Spectrum Disorder; Autistic Disorder; Child; Humans; Nutrients; Sarcosine | 2022 |
3 trials available for dimethylglycine and Autism
Article | Year |
---|---|
Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Topics: Administration, Intranasal; Adolescent; Adult; Autistic Disorder; Double-Blind Method; Facial Expres | 2021 |
A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.
Topics: Adolescent; Adult; Autistic Disorder; Child; Child, Preschool; Cross-Over Studies; Dose-Response Rel | 1999 |
Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder.
Topics: Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Double-Blind Met | 2001 |
1 other study available for dimethylglycine and Autism
Article | Year |
---|---|
Effectiveness of nutritional supplements for reducing symptoms in autism-spectrum disorder: a case report.
Topics: Autistic Disorder; Child; Child Behavior; Communication; Dietary Supplements; Humans; Interpersonal | 2011 |